Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

V Zanni

Showing results (21-30 of 147) with videos related to

Pageof 15
Sort By:
AIDS (London, England)|January 26, 2018
Novel mediators of statin effects on plaque in HIV: a proteomics approachChris deFilippi, Janet Lo, Robert Christenson, et al.
Current HIV/AIDS Reports|October 9, 2021
Cardiovascular Disease Risk Among Transgender People with HIVMadeline Cetlin, Evelynne S Fulda, Sarah M Chu, et al.
Antiviral Therapy|October 9, 2012
Increased FDG uptake in association with reduced extremity fat in HIV patientsMartin Torriani, Markella V Zanni, Kathleen Fitch, et al.
The Journal of Infectious Diseases|May 10, 2023
Osteopontin Is an Integral Mediator of Cardiac Interstitial Fibrosis in Models of Human Immunodeficiency Virus InfectionJake A Robinson, Farina J Mahmud, Elizabeth Greif, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 31, 2018
Cardiovascular Risk Profile of Transgender Women With HIV: A US Health Care Database StudyShawnbir Gogia, Alexandra Coromilas, Susan Regan, et al.
Circulation Research|February 17, 2022
Sexual Dimorphism in Cardiovascular Biomarkers: Clinical and Research ImplicationsEmily S Lau, Aleksandra Binek, Sarah J Parker, et al.
Open Forum Infectious Diseases|January 9, 2019
Impact of the American College of Cardiology/American Heart Association Cholesterol Guidelines on Statin Eligibility Among Human Immunodeficiency Virus-Infected IndividualsMosepele Mosepele, Susan Regan, Joseph Massaro, et al.
Transgender Health|February 24, 2023
Hormone Prescription and HIV Screening/Preventive Practices Among Clinicians Providing Care for Transgender IndividualsMabel Toribio, Madeline Cetlin, Evelynne S Fulda, et al.
HIV Medicine|August 26, 2024
What have we learned from the REPRIEVE trial and where do we go from here?Steven K Grinspoon, Michael T Lu, Markella V Zanni, et al.
JACC. Advances|November 3, 2025
Gender-Affirming Hormone Therapy and Cardiac Structure Among Transgender Women and Gender-Diverse IndividualsMabel Toribio, Vencel Juhasz, Ria Talathi, et al.
Pageof 15

Showing results (21-30 of 147) with videos related to

Sort By:
Pageof 15
AIDS (London, England)|January 26, 2018
Novel mediators of statin effects on plaque in HIV: a proteomics approachChris deFilippi, Janet Lo, Robert Christenson, et al.
Current HIV/AIDS Reports|October 9, 2021
Cardiovascular Disease Risk Among Transgender People with HIVMadeline Cetlin, Evelynne S Fulda, Sarah M Chu, et al.
Antiviral Therapy|October 9, 2012
Increased FDG uptake in association with reduced extremity fat in HIV patientsMartin Torriani, Markella V Zanni, Kathleen Fitch, et al.
The Journal of Infectious Diseases|May 10, 2023
Osteopontin Is an Integral Mediator of Cardiac Interstitial Fibrosis in Models of Human Immunodeficiency Virus InfectionJake A Robinson, Farina J Mahmud, Elizabeth Greif, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|May 31, 2018
Cardiovascular Risk Profile of Transgender Women With HIV: A US Health Care Database StudyShawnbir Gogia, Alexandra Coromilas, Susan Regan, et al.
Circulation Research|February 17, 2022
Sexual Dimorphism in Cardiovascular Biomarkers: Clinical and Research ImplicationsEmily S Lau, Aleksandra Binek, Sarah J Parker, et al.
Open Forum Infectious Diseases|January 9, 2019
Impact of the American College of Cardiology/American Heart Association Cholesterol Guidelines on Statin Eligibility Among Human Immunodeficiency Virus-Infected IndividualsMosepele Mosepele, Susan Regan, Joseph Massaro, et al.
Transgender Health|February 24, 2023
Hormone Prescription and HIV Screening/Preventive Practices Among Clinicians Providing Care for Transgender IndividualsMabel Toribio, Madeline Cetlin, Evelynne S Fulda, et al.
HIV Medicine|August 26, 2024
What have we learned from the REPRIEVE trial and where do we go from here?Steven K Grinspoon, Michael T Lu, Markella V Zanni, et al.
JACC. Advances|November 3, 2025
Gender-Affirming Hormone Therapy and Cardiac Structure Among Transgender Women and Gender-Diverse IndividualsMabel Toribio, Vencel Juhasz, Ria Talathi, et al.
Pageof 15